Beijing Jishi Daze Biological Science & Technology Center

Venture Capital China
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
across known amounts
Stages

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Beijing Jishi Daze Biological Science & Technology Center's primary sector of investment?
Beijing Jishi Daze Biological Science & Technology Center primarily invests in the Health Tech & Life Sciences sector, as evidenced by its single portfolio company.
When did Beijing Jishi Daze Biological Science & Technology Center make its first recorded investment?
Beijing Jishi Daze Biological Science & Technology Center made its first recorded investment in July 2018.
Which company is a notable portfolio company of Beijing Jishi Daze Biological Science & Technology Center?
Nurami Medical is a notable portfolio company of Beijing Jishi Daze Biological Science & Technology Center, having received an investment in July 2018.
What was the investment amount made by Beijing Jishi Daze Biological Science & Technology Center in Nurami Medical?
Beijing Jishi Daze Biological Science & Technology Center invested $2,000,000 in Nurami Medical in July 2018.
Has Beijing Jishi Daze Biological Science & Technology Center acted as a lead investor in any of its funding rounds?
No, Beijing Jishi Daze Biological Science & Technology Center has not acted as a lead investor in any of its recorded funding rounds, with a lead investor share of 0%.
What is the total number of portfolio companies for Beijing Jishi Daze Biological Science & Technology Center?
Beijing Jishi Daze Biological Science & Technology Center has one portfolio company, Nurami Medical, according to startupim data.
What is the investment stage focus for Beijing Jishi Daze Biological Science & Technology Center?
Beijing Jishi Daze Biological Science & Technology Center's recorded investment activity includes one A Round investment.